Engineers Gate Manager’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,135
Closed -$1.13M 2560
2025
Q3
$1.13M Buy
+40,135
New +$1.22M 0.01% 1084
2025
Q2
Sell
-5,454
Closed -$214K 2550
2025
Q1
$214K Sell
5,454
-10,001
-65% -$450K ﹤0.01% 1864
2024
Q4
$718K Sell
15,455
-841
-5% -$38K 0.01% 1207
2024
Q3
$736K Buy
16,296
+6,000
+58% +$285K 0.01% 1182
2024
Q2
$507K Buy
10,296
+2,102
+26% +$85.7K 0.01% 1213
2024
Q1
$281K Sell
8,194
-5,062
-38% -$183K 0.01% 1493
2023
Q4
$489K Sell
13,256
-4,205
-24% -$97.2K 0.01% 1186
2023
Q3
$354K Buy
+17,461
New +$384K 0.01% 1240
2023
Q2
Sell
-27,048
Closed -$408K 2047
2023
Q1
$408K Buy
+27,048
New +$598K 0.02% 1078
2021
Q1
Sell
-4,880
Closed -$689K 2137
2020
Q4
$689K Buy
+4,880
New +$541K 0.03% 776

Other funds holding TWST

Engineers Gate Manager's TWST Position: Q4 2025 in Review

Engineers Gate Manager sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 40,135 shares — an estimated $1.13M sold.

Engineers Gate Manager first reported a position in TWST in Q4 2020 and held it in 10 quarters. The position peaked at $1.13M in Q3 2025. 243 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Engineers Gate Manager reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 40,135 Twist Bioscience shares in Q4 2025, an estimated $1.13M.
  • Engineers Gate Manager first reported a position in Twist Bioscience in Q4 2020 and held it in 10 quarters.
  • Engineers Gate Manager's Twist Bioscience position peaked at $1.13M in Q3 2025.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Engineers Gate Manager's 13F filing for Q4 2025, filed 17 Feb 2026.